Logiscreen

Roivant Sciences Ltd

$40.82
Market Cap 29.36B
ROE -6.1%
Gross Margin 80.3%
Debt/Equity 0.0
Current Ratio 16.7
Revenue QoQ -33.5%
EPS QoQ -0.2%
F-Score 3

About

Roivant Sciences Ltd

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-85.88
vs median 36.93
P/B
5.69
vs median 2.32
ROE
-0.07
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

INSMMRNAUTHRINCYBNTXRPRX
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics